Please login to the form below

Not currently logged in
Email:
Password:

VTE

This page shows the latest VTE news and features for those working in and with pharma, biotech and healthcare.

AbbVie’s upadacitinib aces phase III trial

AbbVie’s upadacitinib aces phase III trial

Crucially for AbbvVie, there were no cases of venous thromboembolism (VTE) in the 1, 629-patent study, something that was observed in two earlier phase III studies of the drug ... Analysts said the lack of VTEs in the latest study reduced the risk in the

Latest news

More from news
Approximately 3 fully matching, plus 45 partially matching documents found.

Latest Intelligence

  • Modern anticoagulants threaten status quo Modern anticoagulants threaten status quo

    It is indicated for the prevention of VTE after orthopaedic surgery and is administered subcutaneously once daily. ... The drug is also in phase III development for the acute treatment of VTE.

  • Case study: Using avatar technology to reduce VTE

    The programme was endorsed by The Royal Pharmaceutical Society and promoted among VTE Exemplar Centres. ... Evidence from the field suggests pharmacists have been encouraged to pick up the gauntlet of VTE prevention.

  • Go with the flow

    risk. VTE risk assessment has been included as a DH priority in the NHS Operating Framework 2010/11.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Market Access Transformation

Founded in 201, Market Access Transformation (MAT) specializes in developing agile technology platforms that enable the healthcare community to exchange...

Latest intelligence

Animation: Living With
The journey from the patient's perspective...
Danny Buckland July2022
Achieving communication excellence by targeting the right channel at the right time
By Danny Buckland...
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....